Martek Pursues Cheaper DHA Cost Structure To Give Ingredient Wider Appeal

Martek Biosciences is working toward substantially lowering the cost of making docosahexaenoic acid (DHA) through a business venture with a genetics seed company

More from Archive

More from Pink Sheet